| Name | [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid |
|---|---|
| Synonyms |
2,6-Diisopropylphenyl [(2,4,6-triisopropylphenyl)acetyl]sulfamate
Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester [2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate 2,6-di(propan-2-yl)phenyl {[2,4,6-tri(propan-2-yl)phenyl]acetyl}sulfamate Avasimibe CI-1011 |
| Description | Avasimibe is an oral inhibitor of acyl-Coenzyme A:cholesterol acyltransferase (ACAT) with IC50s of 24 and 9.2 µM for ACAT1 and ACAT2, respectively. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Melting Point | 178-180° (Lee); mp 169.5-170.4° (Dozeman) |
| Molecular Formula | C29H43NO4S |
| Molecular Weight | 501.721 |
| Exact Mass | 501.291290 |
| PSA | 80.85000 |
| LogP | 9.34 |
| Appearance | white to tan |
| Index of Refraction | 1.529 |
| Storage condition | room temp |
| Water Solubility | DMSO: ≥40mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| RIDADR | NONH for all modes of transport |
|---|---|
| HS Code | 2935009090 |
|
~77%
166518-60-1 |
| Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
|
~%
166518-60-1 |
| Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
|
~%
166518-60-1 |
| Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
|
~%
166518-60-1 |
| Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
|
~%
166518-60-1 |
| Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
|
~%
166518-60-1 |
| Literature: Journal of Medicinal Chemistry, , vol. 39, # 26 p. 5031 - 5034 |
| Precursor 7 | |
|---|---|
| DownStream 0 | |
| HS Code | 2935009090 |
|---|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |